Burjeel Holdings Board Recommends AED 120 Million Dividend for 2025
The Board of Directors of Burjeel Holdings has recommended the distribution of an annual dividend of AED 120 million for the financial year 2025, equivalent to AED 0.02 per ordinary share, following a year of strong financial performance.
The recommendation reflects the group’s ongoing commitment to delivering value to its shareholders while maintaining financial flexibility to support future investments and expansion plans.
Commenting on the company’s performance, Dr. Shamsheer Vayalil, Founder, Chairman and CEO of Burjeel Holdings, said that 2025 marked a significant year for the group, driven by its integrated healthcare network and specialized centres of excellence.
“2025 witnessed strong momentum for Burjeel Holdings, supported by a comprehensive healthcare ecosystem, specialised centres of excellence, and close alignment with national healthcare priorities. Our investments in the healthcare system, combined with our medical leadership and dedicated workforce, have contributed to strong growth and improved quality of earnings, alongside increasing demand for advanced healthcare services,” he said.
The group reported total revenue of AED 5.486 billion in 2025, representing a 9.5 percent year-on-year increase. The growth was driven by rising patient demand, with the number of patient visits exceeding 7 million, marking an 8.4 percent increase compared to the previous year.
Operational performance also improved significantly during the year. Earnings before interest, taxes, depreciation and amortisation (EBITDA) rose by 19.9 percent year-on-year, reaching AED 1.089 billion for the financial year 2025. The EBITDA margin improved to 19.8 percent, compared to 18.1 percent in 2024, reflecting disciplined execution across workforce management, procurement strategies and cost optimisation, as well as increased asset utilisation.
Net profit recorded strong growth as well, increasing 39.5 percent year-on-year to AED 503 million, while the net profit margin expanded to 9.2 percent. The growth reflects improved operational leverage, disciplined management of non-operating costs and gains from asset optimisation initiatives.
Expanding complex and specialised care services remains central to Burjeel Holdings’ medium-term strategy. The company aims to further strengthen its position as a regional leader in medical referrals by deepening clinical expertise in priority specialties and enhancing its surgical and treatment mix to deliver higher value care for patients.
The group also plans to continue its strategic expansion across hospitals, day surgery centres and medical facilities in the United Arab Emirates and Saudi Arabia, supported by integrated referral pathways and growing demand for advanced healthcare services.
Founded in 2007, Burjeel Holdings has become one of the leading private providers of specialised healthcare services in the United Arab Emirates and Oman, while continuing to expand its specialised healthcare offerings in Saudi Arabia.
The group operates an integrated, multi-brand healthcare ecosystem delivering primary, secondary, tertiary and quaternary care services to patients from diverse socio-economic backgrounds.
Today, Burjeel Holdings manages 112 healthcare facilities across the UAE, Oman and Saudi Arabia, including 20 hospitals, 37 medical centres, 30 physiotherapy centres, 15 pharmacies and 10 other supporting service centres.
The group’s healthcare brands include Burjeel, Medeor, LLH, LifeCare, Physiotherabia, Kalma, and Tajmeel, reflecting its broad presence across specialised and general healthcare services in the region.
